Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry.
about
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infectionsIn Vitro Evaluations and In Vivo Toxicity and Efficacy Studies of MFM501 against MRSA.Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE.Acute Angioedema Triggered by Daptomycin
P2860
Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Daptomycin in the Clinical Set ...... from the EU-CORE(SM) Registry.
@ast
Daptomycin in the Clinical Set ...... from the EU-CORE(SM) Registry.
@en
type
label
Daptomycin in the Clinical Set ...... from the EU-CORE(SM) Registry.
@ast
Daptomycin in the Clinical Set ...... from the EU-CORE(SM) Registry.
@en
prefLabel
Daptomycin in the Clinical Set ...... from the EU-CORE(SM) Registry.
@ast
Daptomycin in the Clinical Set ...... from the EU-CORE(SM) Registry.
@en
P2093
P2860
P1433
P1476
Daptomycin in the Clinical Set ...... from the EU-CORE(SM) Registry.
@en
P2093
Armando Gonzalez-Ruiz
Artur Timerman
Jayanta Sarma
Kamel Bouylout
Panayiotis Gargalianos-Kakolyris
Rashidkhan Pathan
Uwe Trostmann
P2860
P2888
P304
P356
10.1007/S12325-015-0220-6
P407
P577
2015-06-25T00:00:00Z